Question 1

What are the potential benefits of trying CV787 compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from this treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

Question 3

How will the dosing work, and how often will I need to come in for treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific eligibility criteria I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

Question 5

What monitoring will be done during the trial to assess my health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

Question 6

How might this treatment fit into my overall cancer care plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer clinical trial (NCT00116155). Contact the study team or your healthcare provider for specific answers.

What this study is about